Reagenzgläser
Vesalius Biocapital

A European life sciences venture capital investor

.

About us

News

Vesalius News

Memo Therapeutics: Positive Phase I Data
read more
CatalYm: Visugromab Development
read more
CatalYm: EUR 50 Million Financing
read more
.

xxnoxx_zaehler